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ABSTRACT

Ayooluwa S. Ayoola, MD
Noel O. Akioyamen, MD

Background: This study investigates the effects of preoperative
carbohydrate-rich drinks on postoperative outcomes after primary total
knee arthroplasty.

W. Trevor North, MD
Michael A. Charters, MD

Methods: We prospectively randomized 153 consecutive patients
undergoing primary total knee arthroplasty at one institution. Patients
were assigned to one of three groups: group A (50 patients) received a
carbohydrate-rich drink; group B (51 patients) received a placebo
drink; and group C (52 patients) did not receive a drink (control). All
healthcare personnel and patients were blinded to group allocation.
Controlling for demographics, we analyzed the rate of postoperative
nausea and vomiting, length of stay, opiate consumption, pain scores,
serum glucose, adverse events, and intraoperative and postoperative
fluid intake.
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Conclusion: This randomized controlled trial demonstrated that
preoperative carbohydrate loading does not improve immediate
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Results: Demographics and comorbidities were similar among the
groups. There were no significant differences in surgical interventions
or experience. Surgical fluid intake and total blood loss were similar
among the three groups (P = 0.47, P = 0.23). Furthermore, acute
postoperative outcomes (ie, pain, episodes of nausea, and length of
stay) were similar across all three groups. There were no significant
differences in adverse events between the three groups (P = 0.13).
There was a significant difference in one-time postoperative bolus
between the three groups (P = 0.02), but after multivariate analysis, it
did not demonstrate significance. None of the intervention group were
readmitted, whereas 5.9% and 11.5% were readmitted in the placebo
and control groups, respectively (P = 0.047). The chance of 90-day
readmission was reduced in group A compared with group C (odds
ratio, 0.08; 95% confidence interval, 0.01 to 0.72; P = 0.02). There
were no differences in other postoperative outcome measurements.
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postoperative outcomes, such as nausea and vomiting; however, it demonstrated that consuming fluid
preoperatively proved no increased risk of adverse outcomes and there was a trend toward decrease of one-time
boluses postoperatively.

Clinical Trials Registry: NCT03380754
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Methods
This study was a prospective, randomized, double-blind,
placebo-controlled study approved by the local institutional review board. After approval, adult patients
scheduled for elective, unilateral, primary TKA were recruited and consented for participation in the study. All
surgeries were done by fellowship-trained orthopaedic
surgeons at a single site in southeast Michigan. Patients
were recruited from July 2017 to April 2019. Patients
were excluded if they had a medical history of impaired
gastrointestinal motility or were on promotility medication, had pregnancy, glycated hemoglobin level greater
than 7.5%, fasting glucose level greater than 200mg/dL,
acquired immunodeficiency, renal failure (creatinine
.2 mg/dL), cirrhosis, or severe malnutrition (body mass
index [BMI] ,20 kg/m2 and/or unintended weight loss of
more than 5% in less than 6 months).
Enrolled patients were randomly assigned to one of three
arms. Group A (intervention group) received a clear, noncarbonated lemon-flavored, iso-osmolar carbohydrate
drink (Nutricia preOp; Nutricia; 12.5% carbohydrates, 50
kcal/100 mL, 260 mOsm/kg, and pH 5.0). Group B (placebo group) received a placebo drink of equal quantity,
which was a clear, lemon-flavored water (Nestle Splash
Lemon; Nestle Waters North America; 0 kcal/100 mL).
Group C (control group) received no drinks. All beverages
were bottled in clear polyethylene terephthalate plastic
International Pharmaceutical Excipients Council (IPEC)
tamper evident bottles. All enrolled patients were given a
kit that included study information, instructions for
participation, a data-collection questionnaire, multiplealarm timer, and two beverage bottles labeled as drink 1
(800 mL) and drink 2 (400 mL). Patients in group C
received a kit that lacked any beverage bottles. Randomization was done before enrollment in blocks of 20.
The drinks were labeled by a research assistant, so neither
patients nor the treatment team was able to identify the
type of beverage or who was assigned to which arm of the
study.
The evening before the surgery, patients in groups A
and B consumed drink 1 of their respective bottles. After
midnight, nothing was allowed by mouth, except for
another morning dose of drink 2. Patients were instructed
to take drink 2 three hours before the scheduled time of
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otal joint arthroplasty (TJA) is one of the most
successful treatment options for managing joint
osteoarthritis.1-3 Surgical outcomes result in
improved quality of life—physically, psychologically, and
economically.4 Within the American healthcare system,
there has been a shift toward value-based reimbursement,
with increased emphasis on the quality of services. This
translates to increased pressure for practicing orthopaedic surgeons to deliver treatments with shorter associated
lengths of stay, lower complication rates, and overall
better outcomes.5-7
As surgical demand for TJA increases, an effort to
increase cost efficiency and patient satisfaction with
surgical outcome requires standardization of the care.
Steps have been taken toward standardizing the care
that patients receive with implementation of enhanced
recovery after surgery (ERAS) protocols. ERAS pathways are programs that include multimodal evidencebased interventions as part of the perioperative care.
The interventions within ERAS protocols are designed
to improve stress response and enhance patient recovery.8 The benefits of certain components of ERAS
protocols have been well established.9-11 When implemented for hip and knee arthroplasty, ERAS has
demonstrated potential to decrease length of stay and
total incidence of postoperative complication.12 One
aspect of ERAS in abdominal surgery literature is the
recommendation of consumption of 300 mL of a clear
carbohydrate-rich drink up to 2 hours before surgical
intervention. However, the literature on the effect of
this ERAS protocol and the consumption of a clear
carbohydrate-rich drink preoperatively in TJA is
lacking.
Within orthopaedic surgery, there have been no
studies conducted that investigate the effect of preoperative carbohydrate loading on immediate postoperative outcomes. The purpose of this study aims to
discover whether consumption of preoperative oral
carbohydrate has an effect on TJA’s immediate postoperative outcomes, primarily postoperative nausea
and vomiting (PONV). We hypothesize that consumption would reduce the incidence of postoperative
nausea without an increased risk of postoperative
complications in patients undergoing elective total
knee arthroplasty (TKA).
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Table 1.

Demographics and Baseline Characteristics by Group

Characteristics

Treatment (N = 50)

Placebo (N = 51)

Control (N = 52)

P Value

67.1 6 7.4

65.3 6 10.2

67.7 6 9.9

0.382

17 (32.7)

0.721

Age (yrs), mean 6 SD
Sex, n (%)
Male

15 (30.0)

Female

13 (25.5)

35 (70.0)

38 (74.5)

35 (67.3)

33.0 6 5.4

31.9 6 5.1

32.5

Black

23 (46.0)

27 (52.9)

21 (40.4)

White

23 (46.0)

23 (45.1)

24 (46.2)

Others

4 (8.0)

1 (2.0)

7 (13.5)

II

22 (44.0)

19 (37.3)

18 (34.6)

III

28 (56.0)

32 (62.8)

34 (65.4)

BMI, mean 6 SD

0.596

Race, n (%)
0.261

ASA score, n (%)
0.606

Diabetes, n (%)
No

39 (78.0)

38 (74.5)

39 (76.5)

Yes

11 (22.0)

13 (25.5)

12 (23.5)

No

42 (85.7)

36 (75.0)

44 (86.3)

Yes

7 (14.3)

12 (25.0)

7 (13.7)

No

42 (84.0)

38 (76.0)

41 (80.4)

Yes

8 (16.0)

12 (24.0)

10 (19.6)

2 (4.0)

1 (2.0)

1 (2.0)

0.918

Nausea/vomit history, n (%)
0.257

Motion sickness history, n (%)
0.633

Smoking history, n (%)
Current
Never

27 (54.0)

28 (54.9)

25 (48.1)

21 (42.0)

22 (43.1)

26 (50.0)

No

44 (88.0)

44 (86.3)

50 (96.2)

Yes

6 (12.0)

7 (13.7)

2 (3.9)

Previous
Opioid use, n (%)

0.865

0.072

ASA = America Society of Anesthesiologists, BMI = body mass index
Demographics compared by the three cohorts. There were no statistically significant differences between the three groups’ characteristics.
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surgery. The patients were instructed and confirmed to
have completed all oral intake by 2 hours before
surgery. Patients in group C had no drinks and were
allowed nothing by mouth (NPO) after midnight. All
other aspects of perioperative care were standardized.
All patients received an epidural of bupivacaine 0.5%
20 mL for anesthesia and 1 dose of 10 mg dexamethasone
preoperatively. The standard postoperative protocol for
nausea and vomiting included making ondansetron 4 mg
available intravenously every 6 hours to all patients. This
was given when the patient endorsed a symptom of
nausea or after a confirmed episode of emesis, when

nausea was not previously documented. No additional
corticosteroid was given during the postoperative phase.
Basic preoperative demographics (ie, age, sex, BMI,
race, and medical history) were collected via electronic
chart review. Intraoperative data included type of anesthesia, incision to closing time, surgical net fluid rate,
intraoperative net fluid given, and total blood loss. Episodes of nausea, vomiting, pain visual analog scale scores
from 0 to 10, and glucose levels were recorded at 0 to 4
hours, 4 to 12 hours, and 12 to 24 hours by members of
the care team and placed in the patient’s electronic
medical record. PONV was defined by vomiting
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Table 2.

Intraoperative Intervention and Characteristics Between the Groups

Characteristics

Treatment (N = 50)

Placebo (N = 51)

Control (N = 52)

P Value

102.5 6 16.4

100.8 6 21.9

100.8 6 17.4

0.508

10.7 6 3.7

11.2 6 3.9

12.1 6 5.0

0.473

1,489.0 6 436.4

1,545.1 6 372.6

1,519.7 6 485.9

0.612

Time from incision to close, mean 6 SD
Surgical net fluid rate (mL/min), mean 6 SD
Intraoperative net fluid (mL), mean 6 SD
Intraoperative blood loss (mL), mean 6 SD
Intraoperative fluid (mL), mean 6 SD

88.8 6 59.7

108.0 6 75.0

79.4 6 46.4

0.225

1,227.4 6 396.3

1,291.6 6 377.2

1,218.1 6 430.5

0.516

138.8 6 18.3

134.8 6 21.6

129.7 6 20.5

0.078

Length in the operating room (min), mean 6 SD

Intraoperative data compared by the three cohorts. P . 0.05 was considered statistically significant. There were no statistically significant
differences between the three groups.

JAAOS®

Results
There were 153 patients enrolled in the study. There were
50 patients in group A, 51 in group B, and 52 in group C.
Demographic data and baseline characteristics were
equal among the groups represented in Table 1.
There were no statistically significant differences in age
(P = 0.38), sex distribution (P = 0.72), race (P = 0.26),
BMI (P = 0.60), or medical history of nausea or vomiting
with surgery (P = 0.31) between the three groups.
There was no significant difference in surgical intervention or experience between the three groups (Table 2).
The surgical length, incision to closing time, was similar
between the three groups, ranging from 100.8 to
102.5 minutes (P = 0.51). There was no difference in the
surgical fluid intake rate (P = 0.47) or estimated blood
loss (P = 0.23).
In-hospital postoperative experience was also similar
across all three groups. There was no difference in patient’s length of stay, opioid consumption, nausea,
vomiting, pain scores, glucose levels, or comfort levels
(Table 3). Length of stay was on average 34.2 hours for
the treatment group and 32 hours for the placebo and
control groups, P = 0.75. In the univariable analysis
(Table 3), postoperative 1-time bolus needs varied
between the groups, with 4 of the individuals in the
intervention group needing a postoperative bolus
compared with 7 and 11 in the placebo and control
groups, respectively (P = 0.02). However, after the
multiple logistic regression model, postoperative bolus
demonstrated no significance (Table 6). By the time 3
(12 to 24 hours postoperatively), confirmed episodes of
emesis ranged from 0% to 14.3% (P = 0.14). There was
no difference in the frequency of nausea or vomiting
episodes at all time intervals. The average pain scores
within 4 hours of surgery ranged from 4.3 to 4.2
between the 3 groups (P = 0.53). Glucose levels within 4
hours of surgery were also comparable (153.2 to
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episodes with visible evidence of emesis recorded by the
nursing staff, and reports of nausea were based on any
use of antiemetic medication. Adverse events were
defined as 90-day postoperative emergency department
visit, readmission, return to the operating room, pulmonary embolism, hematoma, increased length of stay
due to medical necessity, or anesthesia complication.
Preoperative and postoperative physical functions were
assessed using Knee Injury and Osteoarthritis Outcome
Score for Joint Replacement (KOOS JR) and PatientReported Outcomes Measurement Information System
(PROMIS) mental and PROMIS physical scores. Postoperative data were collected between 2 to 14 weeks
after surgery.
All data analyses were done using SAS 9.4 (SAS
Institute), and statistical significance was set at P , 0.05.
All continuous data were described using means, standard deviations, medians, minimums, maximums, 25th
percentiles, and 75th percentiles and were compared
between groups using the analysis of variance or
Kruskal-Wallis test based on normality assumptions. All
categorical variables were presented as frequencies and
column percentages. Categorical variables were compared using the chi square test of independence or Fisher
exact test if conditions were not met. Minimally clinically important difference was calculated for KOOS JR
and PROMIS scores via one-half the standard deviation
of the mean scores. Multivariable logistic or linear
regression models were used with results presented as
adjusted odds ratios and 95% confidence intervals or
estimate and standard error, respectively.
The cohorts were divided into a sample size of 50 per
group for a total of 150 individuals. The minimum
rejection level used with the Hochberg method was
0.0167. The 2-sided test with 50 patients in each group
had 80% power to detect a difference in the PONV rate
from 40% in the control group to 12.1% in the carbohydrate group.
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Table 3.

Immediate Postoperative Outcomes

Perioperative Outcomes
Length of stay (hr)

Treatment (N = 50)

Placebo (N = 51)

Control (N = 52)

P Value

34.2 6 8.3

36.5 6 13.1

38.0 6 22.9

0.703

Nausea (time 1)

0.506

No

70.8%

83.9%

79.0%

Yes

29.2%

16.1%

21.1%

Nausea (time 2)

0.290

No

78.3%

83.9%

65.0%

Yes

21.7%

16.1%

35.0%

Nausea (time 3)

0.228

No

91.3%

87.1%

71.4%

Yes

8.7%

12.9%

28.6%

Vomiting (time 1)

0.801

No

91.7%

90.0%

85.0%

Yes

8.3%

10.0%

15.0%

No

87.0%

93.6%

81.0%

Yes

13.0%

6.5%

19.1%

Vomiting (time 2)

0.363

Vomiting (time 3)

0.135

No

100.0%

Yes

93.6%

85.7%

0%

6.5%

14.3%

Postoperative pain (time 1), mean 6 SD

4.3 6 2.4

4.7 6 2.5

4.2 6 2.5

0.534

Postoperative pain (time 2), mean 6 SD

3.6 6 2.2

3.7 6 2.4

3.2 6 2.1

0.493

Postoperative pain (time 3), mean 6 SD

3.2 6 2.0

3.5 6 2.1

3.1 6 1.9

0.626

Glucose (time 1), mean 6 SD

153.2 6 26.8

165.9

164.4

0.697

Glucose (time 2), mean 6 SD

165.3 6 42.1

177.9 6 43.8

176.2 6 39.2

0.137

Glucose (time 3), mean 6 SD

125.9 6

132.2 6 36.0

127.2 6 20.7

0.388

57.0 (0-232.5)

62.0 (0-270.5)

61.0 (0-423)

0.906

Postoperative opiate, mean 6 SD
a

Postoperative bolus

0.023

No

46 (91.3%)

44 (84.1%)

41 (73.2%)

Yes

4 (8.7%)

7 (15.9%)

11 (26.8%)

a

Total opioid consumed in morphine milligram equivalent.
Time 1 refers to data collected from 0 to 4 for hours postoperatively; time 2: 4 to 12 hours postoperatively; and time 3: 12 to 24 hours
postoperatively.
No statistically significant difference was found during in-hospital postoperative events. Postoperative fluid requirements demonstrated that
patients within the treatment group compared with those in the control group demonstrated a significantly higher incidence of postoperative
one-time boluses (P = 0.02). There was no significant difference between the cohorts in intraoperative fluid intake.
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165.9 mg/dL) in all 3 groups (P = 0.70). Mean opioid
consumption for each group ranged from 57.0 to 61.0
morphine milliequivalents (P = 0.91) (Table 3).
Furthermore, there was no significant difference in 90day postoperative events, except for readmission. The
readmission rate for group A was 0%, group B was
5.9%, and group C was 11.5% (P = 0.047) (Table 4). In
addition, all groups had similar postoperative KOOS JR

and PROMIS physical and mental scores at follow-up
(Table 5). There was no difference in the ratio of patients
whose scores achieved minimally clinically important
difference for KOOS JR, PROMIS mental, or PROMIS
physical, P = 0.84, P = 0.69, and P = 0.65, respectively.
Controlling for the significant preoperative demographics, including sex, age, race, BMI, America Society
of Anesthesiologists score, medical history of diabetes,
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Table 4.

90- Day Adverse Events by Group

Adverse Events

Treatment (N = 50)

Placebo (N = 51)

Control (N = 52)

ER visit (n, %)

4 (8.0)

4 (7.8)

5 (9.6)

Hematoma (n, %)

1 (2.0)

0

0

44 (88.0)

40 (78.4)

41 (78.9)

1 (2.0)

3 (5.9)

0

0

1 (2.0)

0

No (n, %)

44 (88.0)

40 (78.4)

41 (78.9)

Yes (n, %)

6 (12.0)

11 (21.6)

11 (21.2)

No (n, %)

46 (92.0)

47 (92.2)

47 (90.4)

Yes (n, %)

4 (8.0)

4 (7.8)

5 (9.6)

No 90 d event (n, %)
Other (n, %)
PE (n, %)

P-Value

0.130

No 90 d event

ED visit

0.373

1.000

Readmission

0.047

No (n, %)

50 (100.0)

48 (94.1)

46 (88.5)

Yes (n, %)

0

3 (5.9)

6 (11.5)

Return to OR

0.174

No (n, %)

49 (98.0)

48 (94.1)

52 (100.0)

Yes (n, %)

1 (2.0)

3 (5.9)

0

No (n, %)

50 (100.0)

50 (98.0)

52 (100.0)

Yes (n, %)

0

1 (2.0)

0

PE

Hematoma

0.327

No (n, %)

49 (98.0)

51 (100.0)

52 (100.0)

Yes (n, %)

1 (2.0)

0

0

ED = Emergency Department, OR = Operating room, PE = Pulmonary Embolism
P , 0.05 represents statistical significance.
Readmission rates were increased in control and placebo group compared with intervention group (P = 0.047). No statistically significant
difference in all other 90-d postoperative events.
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This study assesses the effect that carbohydrate loading
has on immediate postoperative outcomes, primarily
preventing postoperative nausea, in patients who
undergo TKA. The findings of this study demonstrate

that although there may be no benefit to preoperative
carbohydrate-rich drink regarding postoperative nausea
and vomiting, pain scores, or glucose control, it is a safe
option for patients with no notable effect on immediate
postoperative outcomes.
Historically, there have been no studies conducted
that strictly evaluate the relationship between preoperative carbohydrate drinks and PONV in patients receiving
TKA. This study agrees with the systematic review conducted by Smith et al.13 In the 27 studies identified, the
1,976 patients who received preoperative carbohydrate
supplementation did not demonstrate statistically significant decreases in PONV compared with other patients. By contrast, there is literature stating that
administering 5% dextrose preoperatively can markedly
reduce PONV.14 These conflicting findings suggest the
need for additional studies around the subject.

Month 2022, Vol 00, No 00
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smoking status, and history of postoperative nausea
and vomiting, Table 6 demonstrates no significant
increase in the odds of having an adverse event
between the three groups, except for readmission. The
intervention group had a decreased risk of readmission compared with the control group (odds ratio,
0.08; 95% confidence interval, 0.01 to 0.72; P =
0.02). No difference was seen between the control and
placebo groups (P = 0.216).
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Table 5.

Preoperative and Postoperative Patient-reported Outcomes

Assessments
Preoperative KOOS JR (N)
Mean 6 SD
Preoperative PROMIS mental (N)
Mean 6 SD
Preoperative PROMIS physical (N)
Mean 6 SD
Postoperative KOOS JR (N)
Mean 6 SD
Postoperative PROMIS mental (N)

Treatment

Placebo

Control

28

22

23

49.8 6 10.3

45.1 6 13.7

50.8 6 18.2

28

21

22

52.4 6 5.3

48.8 6 8.2

48.2 6 10.1

28

21

23

41.5 6 5.3

38.9 6 6.7

39.0 6 7.5

23

24

24

68.8 6 14.2

68.5 6 15.6

62.9 6 19.8

P Value
0.353

0.153

0.047

0.358

22

24

23

53.0 6 6.3

53.0 6 8.1

49.6 6 7.5

23

23

24

45.9 6 6.6

46.5 6 6.8

42.9 6 7.2

0.232

No

5 (31.5)

3 (25.0)

5 (38.5)

0.841

Yes

11 (68.8)

9 (75.0)

8 (61.5)

No

12 (75.0)

7 (58.3)

7 (63.6)

Yes

4 (25.0)

5 (41.7)

4 (36.4)

No

8 (50.0)

4 (33.3)

5 (38.5)

Yes

8 (50.0)

8 (66.7)

8 (61.5)

Mean 6 SD
Postoperative PROMIS physical (N)
Mean 6 SD

0.232

KOOS JR MCID

PROMIS mental MCID
0.690

PROMIS physical MCID
0.652

KOOS JR = Knee Injury and Osteoarthritis Outcome Score for Joint Replacement, MCID = minimal clinically important difference, PROMIS =
Patient-Reported Outcomes Measurement Information System
P , 0.05 is considered statistically significant.
Preoperative PROMIS Physical varied between the three groups, with the intervention group having the highest score and the placebo group
having the lowest (P = 0.047). No other statistically significant differences were observed in physical or mental function tests.
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Postoperative fluid management remains a controversial aspect of surgical care, with restrictive fluid regimens and goal-directed fluid therapy being the leading
recommendations.8 Patients receive postoperative fluid
replacements to mitigate perioperative dehydration,
which is often associated with nausea and vomiting.15
Preoperative fasting contributes to perioperative hypovolemia.16 The additional 1,200 mL of fluid given to the
treatment and control groups in this study did not pose
an increased adverse effect to the patients. There are few
studies that evaluate the postoperative fluid status of
patients after carbohydrate loading. Ljunggren and
Hahn17 found that preoperative water or nutritional
drink did not affect a patient’s hemodynamic status.
This study demonstrated that patients receiving postoperative boluses were trending different between the
treatment and control groups. This finding could indicate that those patients who are not having notable

postoperative need for fluid could avoid boluses with
preoperative fluid intake.
Ninety-day postoperative outcomes have become a
popular topic in the arthroplasty literature in the past decade
because of the federal Medicaid/Medicare reimbursement
policies.18,19 This study aimed to demonstrate that providing patients preoperative oral fluids was comparably as
safe as an NPO status in today’s arthroplasty ERAS protocol. Many arthroplasty patients have difficulty maintaining appropriate hydration at their age, which with an
NPO status preoperatively can exacerbate dehydration.20,21 This can lead to increased fluid intraoperatively
or postoperatively, which then leads to additional complications for many comorbidities.22 Therefore, this study
has demonstrated that patients who presented preoperatively after oral fluid intake had similar immediate and
90-day postoperative outcomes and patient-reported
outcomes. In fact, the treatment group demonstrated a
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Table 6.

Multivariate Logistic Models Controlling for Sex, Age, Race, BMI, ASA Score, DM, Smoking, and Other
Preoperative Conditions
Group

OR (95% CI)

P Value

A versus C

0.68 (0.17-2.65)

0.578

B versus C

1.23 (0.35-4.26)

0.748

Outcome
Incidence of vomiting

Antinausea medication

90-d AE event

ED visit

Readmission

Postoperative bolus

Postoperative pain (time 1-3)

a

KOOS JR MCID

PROMIS mental MCID

PROMIS physical MCID

A versus C

0.63 (0.26-1.51)

0.296

B versus C

0.55 (0.23-1.34)

0.188

A versus C

0.49 (0.15-1.55)

0.223

B versus C

1.14 (0.39-3.34)

0.808

A versus C

0.93 (0.25-3.46)

0.911

B versus C

1.02 (0.26-3.96)

0.980

A versus C

0.08 (0.01-0.72)

0.024

B versus C

0.40 (0.10-1.70)

0.216

A versus C

0.72 (0.26-1.99)

0.532

B versus C

1.07 (0.41-2.81)

0.895

A versus C

20.05 (0.49)

0.911

B versus C

0.31 (0.50)

0.536

A versus C

2.34 (0.27-19.89)

0.443

B versus C

1.21 (0.11-13.04)

0.875

A versus C

1.36 (0.13-13.95)

0.795

B versus C

2.38 (0.15-38.83)

0.544

A versus C

1.72 (0.26-11.13)

0.572

B versus C

2.28 (0.25-20.73)

0.464

A = intervention group, B = placebo group, C = control group, AE = adverse event, ASA = America Society of Anesthesiologists, BMI = body
mass index, CI = confidence interval, DM = diabetes mellitus, ED = emergency department, KOOS JR = Knee injury and Osteoarthritis
Outcome Score for Joint Replacement, MCID = minimal clinically important difference, OR = odds ratio, PROMIS = Patient-Reported
Outcomes Measurement Information System
a
Multivariate linear regression model.
P , 0.05 is considered statistically significant.
There are increased odds of readmission in the control group compared with the intervention group (OR, 0.08; P = 0.024). No other statistically
significant differences were observed in risks of postoperative complications when controlled for preoperative conditions. No statistically
significant difference was found in odds of experiencing postoperative pain.

JAAOS®

during the postoperative period. So, it is possible that not
all data were recorded or collected. Another limitation is
the influence of epidural anesthesia on PONV. Perioperative anesthetics could have influenced the incidence
of PONV because different approaches to anesthesia
have their benefits and drawbacks.17 In comparison to
local infiltration anesthesia for pain control in TKA,
epidural use in this setting has demonstrated higher
incidence of PONV.23 In choosing the appropriate
anesthetic regimen, providers must reconcile the benefits
and pitfalls of established protocols with patient-specific
variables, such as allergies, urinary retention, and tolerance of delayed ambulation.24 These considerations can make it difficult to minimize PONV risk. In
our study, however, all patients received the same
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decreased readmission rate even after controlling for sex,
age, race, BMI, America Society of Anesthesiologists score,
medical history of diabetes, smoking status, and history of
postoperative nausea and vomiting.
There are limitations to this study. Because of the high
incidence of postoperative nausea and vomiting, a cohort
of 153 patients offers acceptable power. However, this is
not necessarily true with the secondary findings, and any
significance should be treated more as a trend versus
clinical significance. In addition, the accuracy of information collected via electronic chart review cannot be
verified because of unstandardized input from individual
healthcare providers. There were no standardized instructions given to nurses and other members of the care
team regarding the importance of strict documentation
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9. Bardram L, Funch-Jensen P, Jensen P, Kehlet H, Crawford ME:
Recovery after laparoscopic colonic surgery with epidural analgesia,
and early oral nutrition and mobilisation. Lancet 1995;345:763-764.

Conclusion

10. Miller TE, Thacker JK, White WD, et al: Reduced length of hospital stay
in colorectal surgery after implementation of an enhanced recovery
protocol. Anesth Analg 2014;118:1052-1061.

This randomized controlled trial suggests that neither
carbohydrate loading nor simple hydration poses an
increase in postoperative complications compared
with a standard fasting group, although there is not
enough evidence to support the recommendation of
preoperative carbohydrate loading for elective TKA for
the reduction of postoperative nausea and vomiting and
reduced discomfort postoperatively. Therefore, the
study provides level 1 evidence that under this protocol,
preoperative hydration and carbohydrate loading causes no harm to patients’ postoperative recovery.
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anesthetics and had the same medical treatment option
available to them.

